Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination

Understanding the patient experience of treatment toxicities and their impact on health-related quality of life from cancer treatments requires asking patients using patient-reported outcomes. Over the past 20 years, the National Institutes of Health has sponsored several tools-namely, Patient-Reported Outcomes Measurement Information System measures and the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events-for precisely this purpose: to ensure valid, reliable tools to collect and detect patient-reported toxicities or adverse events and their impact on health-related quality of life. These patient-reported outcomes measures have been widely incorporated in clinical trials for adults with cancer. Yet, despite considerable work developing and validating developmentally appropriate versions of these measures for pediatric and adolescent self-report, patient-reported outcomes inclusion in pediatric and adolescent and young adult clinical trials has lagged. Here, we discuss optimal strategies to integrate validated patient-reported outcomes tools and sound analytic methodologies in clinical trials for children and adolescent and young adults with cancer, highlighting lessons learned from recent successes and ongoing experiences developing and opening cross-network trials for children and adolescent and young adults through the Children's Oncology Group for patients with classic Hodgkin lymphoma, osteosarcoma, and acute lymphoblastic leukemia.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-03-31
DOI
https://doi.org/10.1093/jnci/djaf083
Citations
3
Primary Topic
Childhood Cancer Survivors' Quality of Life
Type
article
Field-Weighted Citation Impact
10.48

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination

Susan K. Parsons, Pamela S. Hinds, Lindsay Anne Renfro, Damon R. Reed et al.
3 citations
JNCI Journal of the National Cancer Institute
Childhood Cancer Survivors' Quality of Life
10.48
article

Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination

Susan K. Parsons, Pamela S. Hinds, Lindsay Anne Renfro, Damon R. Reed, Sharon M. Castellino, Katie A. Greenzang, Natalie DelRocco, Michael Roth, Kathleen Montgomery, Katherine A. Janeway, Adam DuVall, Michelle M. Nuño, Jennifer L. McNeer, Mark Krailo, Maureen M. O’Brien, John J. Doski, Sue Zupanec, Kara M. Kelly
article en
3 citations

Abstract

Understanding the patient experience of treatment toxicities and their impact on health-related quality of life from cancer treatments requires asking patients using patient-reported outcomes. Over the past 20 years, the National Institutes of Health has sponsored several tools-namely, Patient-Reported Outcomes Measurement Information System measures and the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events-for precisely this purpose: to ensure valid, reliable tools to collect and detect patient-reported toxicities or adverse events and their impact on health-related quality of life. These patient-reported outcomes measures have been widely incorporated in clinical trials for adults with cancer. Yet, despite considerable work developing and validating developmentally appropriate versions of these measures for pediatric and adolescent self-report, patient-reported outcomes inclusion in pediatric and adolescent and young adult clinical trials has lagged. Here, we discuss optimal strategies to integrate validated patient-reported outcomes tools and sound analytic methodologies in clinical trials for children and adolescent and young adults with cancer, highlighting lessons learned from recent successes and ongoing experiences developing and opening cross-network trials for children and adolescent and young adults through the Children's Oncology Group for patients with classic Hodgkin lymphoma, osteosarcoma, and acute lymphoblastic leukemia.

JNCI Journal of the National Cancer InstituteVol. 117(9)
University of Southern California (US), Tufts University (US), Boston Children's Hospital (US), Tufts Medical Center (US), Roswell Park Comprehensive Cancer Center (US), Primary Children's Hospital (US), Emory Healthcare (US), Memorial Sloan Kettering Cancer Center (US), Children's National (US), The University of Texas MD Anderson Cancer Center (US), University of Wisconsin–Madison (US), Emory University (US), The University of Texas at San Antonio Health Science Center (US), George Washington University (US), University of Utah (US), Hospital for Sick Children (CA), University of Chicago (US), Madison Group (United States) (US), Urology San Antonio (US), Children's Hospital Colorado (US), New York Proton Center (US), Aflac (United States) (US), Dana-Farber Cancer Institute (US), Children's Healthcare of Atlanta (US), Denver School of Nursing (US), Jacobs Institute (US), Jacobs (United States) (US), Boston Children's Museum (US), University of Colorado Anschutz Medical Campus (US), University at Buffalo, State University of New York (US), University of Colorado Denver (US)
National Institutes of Health, National Cancer Institute
Reduced inequalities
Openalex Percentile: Top 3%
Childhood Cancer Survivors' Quality of Life
10.48
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.